These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


121 related items for PubMed ID: 2435245

  • 21. [[Neoadjuvant chemotherapy (cisplatin, doxorubicin, cyclophosphamide) in the treatment of invasive urothelial tumors of the bladder. Preliminary results of a prospective study concerning 22 patients].
    Trifard F, Chrétien Y, Vallantin X, Collet C, Lachand AT, Dufour B.
    Ann Urol (Paris); 1988; 22(3):216-9. PubMed ID: 3401004
    [Abstract] [Full Text] [Related]

  • 22. [Therapeutic experiences of cis-diamminedichloroplatinum, adriamycin and 5-fluorouracil combination chemotherapy in advanced urothelial cancer, with special reference to adjuvant chemotherapy in invasive urothelial cancer].
    Ogawa O, Yoshimura N, Taniguchi T, Nishimura K, Nakagawa T.
    Hinyokika Kiyo; 1986 Jun; 32(6):795-802. PubMed ID: 3766338
    [Abstract] [Full Text] [Related]

  • 23. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N.
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [Abstract] [Full Text] [Related]

  • 24. High-dose intensity, circadian-timed doxorubicin and cisplatin adjuvant chemotherapy for bladder cancer.
    Hrushesky WJ, Roemeling RV, Wood PA, Langevin TR, Lange P, Fraley E.
    Cancer Treat Rep; 1987 Oct; 71(10):915-9. PubMed ID: 3652055
    [Abstract] [Full Text] [Related]

  • 25. [Multivariate evaluation of survival factors and postoperative adjuvant chemotherapy in patients with bladder cancer treated by radical cystectomy].
    Takashi M, Murase T, Aota Y, Nagai T, Kinjo T, Sabashi M, Shimoji T, Miyake K, Hamajma N, Mizuno S.
    Hinyokika Kiyo; 1988 Aug; 34(8):1377-81. PubMed ID: 2461643
    [Abstract] [Full Text] [Related]

  • 26. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience.
    Stöckle M, Meyenburg W, Wellek S, Voges GE, Rossmann M, Gertenbach U, Thüroff JW, Huber C, Hohenfellner R.
    J Urol; 1995 Jan; 153(1):47-52. PubMed ID: 7966789
    [Abstract] [Full Text] [Related]

  • 27. [Systemic cisplatin-based chemotherapy in the treatment of advanced bladder cancer].
    Boccon-Gibod L, Guinet F, Cressey-Kanoui C, Debré B, Steg A.
    Ann Urol (Paris); 1985 Jan; 19(4):239-43. PubMed ID: 4040730
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Combination chemotherapy of cyclophosphamide, adriamycin and cisplatin in advanced urothelial cancer].
    Nakagawa S, Nakao M, Toyoda K, Nukui M, Takada H, Ebisui K, Watanabe H, Furusawa T, Maegawa M, Kaiho H.
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3071-7. PubMed ID: 3674892
    [Abstract] [Full Text] [Related]

  • 30. Chemotherapy in the post-MVAC era: the case for adjuvant chemotherapy.
    Lehmann J, Retz M, Stöckle M.
    World J Urol; 2002 Aug; 20(3):144-50. PubMed ID: 12196897
    [Abstract] [Full Text] [Related]

  • 31. Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes.
    Hudis CA, Seidman AD, Baselga J, Raptis G, Lebwohl D, Gilewski T, Currie V, Moynahan ME, Sklarin N, Fennelly D.
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):18-23. PubMed ID: 8643965
    [Abstract] [Full Text] [Related]

  • 32. [Chemotherapy of urothelial cancer with vincristine, mitomycin C, bleomycin, tegafur and OK-432].
    Fujihiro S, Takeuchi T, Fujimoto Y, Okano M, Horie M, Kanematsu M, Kuriyama M, Ban Y, Nishiura T.
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):427-32. PubMed ID: 6200077
    [Abstract] [Full Text] [Related]

  • 33. [Combination chemotherapy of advanced bladder cancer].
    Kiyohara H.
    Hinyokika Kiyo; 1986 Dec; 32(12):1925-30. PubMed ID: 3825829
    [Abstract] [Full Text] [Related]

  • 34. [Neoadjuvant chemoradiotherapy in locally invasive transitional cell carcinoma of the urinary bladder: early results of PVB and CAP therapy].
    Momose H, Arai K, Nakagawa Y, Fujimoto K, Tsujimoto S, Cho M, Tani Y, Saka M, Nakatsuji F, Iwai A.
    Hinyokika Kiyo; 1989 May; 35(5):781-8. PubMed ID: 2478001
    [Abstract] [Full Text] [Related]

  • 35. Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma.
    Burke TW, Gershenson DM, Morris M, Stringer CA, Levenback C, Tortolero-Luna G, Baker VV.
    Gynecol Oncol; 1994 Oct; 55(1):47-50. PubMed ID: 7959265
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Evaluation of chemotherapy in advanced urothelial carcinoma: with special reference to combination chemotherapy with adriamycin, cyclophosphamide and cisplatin (ACE chemotherapy)].
    Tobisu K, Matsumoto K, Takai K, Kakizoe T.
    Nihon Hinyokika Gakkai Zasshi; 1987 Feb; 78(2):327-34. PubMed ID: 3613336
    [No Abstract] [Full Text] [Related]

  • 38. [Response to chemotherapy in endocrine therapy-relapsed and -resistant prostate cancer].
    Akimoto S, Akakura K, Masai M, Shimazaki J.
    Hinyokika Kiyo; 1991 Jan; 37(1):31-7. PubMed ID: 1707216
    [Abstract] [Full Text] [Related]

  • 39. [Non-cross-resistant sequential combination chemotherapy consisting of cis-diammine-dichloroplatinum (II) mainly, based on synchronization theory, in human bladder cancer xenografts in athymic nude mice].
    Yamauchi T, Okada K, Yoshida O.
    Hinyokika Kiyo; 1986 Dec; 32(12):1781-97. PubMed ID: 2435129
    [Abstract] [Full Text] [Related]

  • 40. [Multidisciplinary treatment of head and neck cancer].
    Inuyama Y, Fujii M, Tanaka J, Takaoka T, Hosoda H, Kohno N.
    Gan No Rinsho; 1985 Jul; 31(9 Suppl):1051-6. PubMed ID: 2414482
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.